Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION)
Document Type
Journal Article
Publication Date
2012
Journal
HIV Medicine
Volume
13
Issue
4
Inclusive Pages
236-244
APA Citation
Arasteh, K., Ward, D., Plettenberg, A., Livrozet, J., & Orkin, C. (2012). Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION). HIV Medicine, 13 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/3077
COinS